A feasibility study comparing two strategies of oral contrast in patients undergoing contrast-enhanced abdominal CT: 50 ml Télébrix Gastro + 950 ml water vs 1000 ml water only.
Completed
- Conditions
- not applicable100179901001965410017991
- Registration Number
- NL-OMON44229
- Lead Sponsor
- Academisch Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 200
Inclusion Criteria
Patients scheduled to undergo an abdominal CT with oral contrast at the department of Radiology;
Outpatients;
> 18 years.
Exclusion Criteria
Patients undergoing CT for other research purpose;
Patients who are not willing to participate;
Not able to understand and/or give written informed consent
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Primary parameters: quality of the scans and the diagnostic confidence by the<br /><br>radiologist. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Secondary parameters: patients discomfort and radiation exposure. </p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of Télébrix Gastro in enhancing abdominal CT contrast visualization?
How does oral contrast with Télébrix Gastro compare to water-only in CT imaging for gastrointestinal tract disorders?
Are there specific biomarkers that predict optimal oral contrast agent performance in abdominal CT scans?
What adverse events are associated with Télébrix Gastro administration during contrast-enhanced CT procedures?
What alternative oral contrast agents are being evaluated for abdominal CT in observational studies like NL-OMON44229?